Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen Listeria monocytogenes.
The effects of exogenously administered human recombinant IL-2 (hrIL-2) on resistance to Listeria monocytogenes infection were examined. Intravenous injection of hrIL-2 significantly enhanced antibacterial resistance in both BDF1 and C3H/HeJ mice. The beneficial effect of hrIL-2 was observed with as...
Sparad:
| I publikationen: | Infect Immun |
|---|---|
| Huvudupphov: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
1989
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC260764/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2789191/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.57.10.3014-3021.1989 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
